Atsena Therapeutics

Atsena Therapeutics is a clinical-stage gene therapy company dedicated to developing innovative treatments that can reverse or prevent blindness caused by inherited retinal diseases. Their mission is to improve the quality of life for patients suffering from these conditions through the discovery and development of groundbreaking gene therapies. Atsena's pipeline includes cutting-edge treatments for X-linked retinoschisis (XLRS), Leber congenital amaurosis 1 (LCA1), and MYO7A-associated Usher syndrome (USH1B).

Atsena's approach is driven by their novel adeno-associated virus (AAV) technology platform, specifically tailored to overcome the challenges associated with inherited retinal diseases. This technology platform, combined with their experienced team of scientists and clinicians, positions Atsena as a leader in the field of ocular gene therapy. They are committed to responsible stewardship of resources and transparency in all aspects of their business.

Atsena Therapeutics is committed to employing a diverse workforce, regardless of location, and actively optimizes virtual collaboration and communication practices, aiming for an effective balance between in-person and virtual teamwork. This allows for greater flexibility in working arrangements, with some positions offering remote work opportunities. The company is dedicated to treating all people with respect and compassion.

Atsena Therapeutics is committed to providing its employees with a comprehensive benefits package, designed to support their wellbeing and career growth. These benefits include health insurance, dental insurance, vision insurance, and life insurance. The company also offers a generous paid time off policy and paid parental leave. Additionally, they provide a 401(k) retirement savings plan with a company match. Atsena also fosters a collaborative and inclusive work environment, prioritizing a balance between in-person and virtual teamwork to enable efficient communication and flexible work arrangements.

Atsena Therapeutics is a clinical-stage gene therapy company dedicated to improving the lives of patients with inherited retinal diseases by developing best-in-class treatments that prevent or reverse blindness. They strive to create technologies that deliver targeted solutions for ocular diseases and are committed to addressing the needs of patients with vision loss.

Atsena Therapeutics fosters a culture centered on collaboration, innovation, and patient-centricity. They prioritize creating an inclusive and diverse workforce, embracing both in-person and virtual teamwork. The company values scientific excellence, integrity, and urgency in bringing cutting-edge gene therapies to the clinic, while also demonstrating a commitment to responsible stewardship of resources and ethical conduct in all aspects of their business.

Atsena Therapeutics is committed to building a diverse, equitable, and inclusive workplace. They strive to attract and retain talented individuals from all backgrounds, regardless of location, and treat everyone with respect and compassion. Their focus is on optimizing virtual collaboration and communication practices while also creating an efficient physical footprint that allows for a balanced approach to in-person and virtual teamwork.